InvestorsHub on MSN
VolitionRx shares jump as feline cancer blood test delivers strong accuracy results
Volitionrx Ltd (NYSE:VNRX) shares rallied 18.5% on Thursday after the company unveiled encouraging performance data for its feline cancer screening test. The epigenetics-focused group said its Nu.Q® ...
HENDERSON, Nev., Jan. 8, 2026 /PRNewswire/--VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces results from a ...
HENDERSON, Nev., Jan. 8, 2026 /PRNewswire/ -- VolitionRx Limited (VNRX) ("Volition"), a multi-national epigenetics company, announces results from a clinical study demonstrating the high accuracy of ...
VolitionRx Limited: VolitionRx Announces Breakthrough Clinical Data for Nu.Q Vet Cancer Test in Cats
Paves the Way for World's First Feline Liquid Biopsy Test for Cancer Detection HENDERSON, Nev., Jan. 8, 2026 /PRNewswire/--VolitionRx Limited (NYSE AMERICAN: VNRX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback